chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Became sick with flu like symptoms  Constant sneezing, runny nose, and itchy ears
3hrs post vax pt exp paleness, goosebumps, & seemed weak this afternoon lasted 1 hr;
Discharge Provider: Private MD Primary Care Provider at Discharge: Private MD  Admission Date: 8/13/2022 Discharge Date:  8/15/2022 PRESENTING PROBLEM: COVID-19 [U07.1]; COVID-19 virus infection [U07.1] HOSPITAL COURSE: The patient is a 76-year-old female with a history of essential hypertension, hypothyroidism, history of microadenoma as well as advanced dementia, who currently lives with her husband who cares for her.  Patient's husband developed a COVID infection approximately 1 week prior to admission. The patient developed a slight cough with increasing weakness 2 days prior to admission. The patient's husband noted that she was too weak to stand, and he brought her to the ER on 07/13/2022. The patient's mental status was noted to be at baseline, being oriented to only her 1st name. The patient was found to be positive for COVID although chest x-ray was negative for infiltrate, the patient was afebrile with stable O2 saturations on room air. Patient was admitted for further observation given her increasing weakness. For her COVID infection she was treated with cough suppressants, and supportive care, with no indication for remdesivir or dexamethasone. The patient was seen by PT/OT who recommended discharge to home with assistance. The patient was seen by care management, and at discharge was set up with home nursing, PT, and OT. As patient was clinically stable, she was discharged 8/15/2022.
Dose 1: Extreme pain, swelling, itching, burning on day 9 for 14 days. Treated with steroids & antibiotic because redness & stinging spread. Dose 2: 12 hrs after injection, severe headache, chills, fever, lethargy, extreme fatigue, shortness of breath for 39 hrs. Shortness of breath & fatigue have persisted into 4th day.
a patient received a partial dose of Fluzone High Dose Quadrivalent/ NO AE; a patient received partial dose of Fluzone High Dose Quadrivalent due to a needle malfunction/ NO AE; Initial information received on 22-Sep-2020 regarding an unsolicited valid non-serious case from the other health care professional.  This case involves a 65-years-old female patient who received a partial dose of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] (single dose vial, frequency: yearly, lot number: UJ450AB, expiry date: 30-Jun-2021 via an intramuscular route in the left deltoid) due to a needle malfunction (underdose and needle issue) on 22-Sep-2020 for prophylactic vaccination.  The patient's medical history, past medical treatment, concomitant medication and family history were not provided.  No other vaccinations were used.  It was a case of vaccine underdose and needle issue (latency: same day)  The patient experienced no adverse event.  Product technical complaint (PTC) assessment: Physical.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Flare ups; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (Flare ups) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Giant cell arteritis (other giant cell arteritis).    On 16-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021, the patient experienced CONDITION AGGRAVATED (Flare ups). At the time of the report, CONDITION AGGRAVATED (Flare ups) outcome was unknown.            No concomitant medication information provided. No treatment information provided.
Patient diagnosed with COVID on 1/17/22 by her PCP.  She states she did pretty well initially but then began having n/v and started feeling poorly with worsening SOB and therefore presented to the ED.
Patient walked to front of office and stated he felt nauseous and then fainted. Patient stated he could not see, was pale in color and diaphoretic. Patient was placed in a chair, VS were taken and within approx 5 min patient was able to stand and ambulate on his own.
A non-serious spontaneous report of allergic reaction has been received from a Registered Nurse concerning a five-year-old male, subsequent to receiving FLUMIST. No medical history was report for this subject; concomitant medications included vaccines given the same day as FLUMIST including DTAP, Polio, MMR and Varicella. The patient received FLUMIST on 27-Aug-2009. The reporter indicated that within minutes of receiving FLUMIST the patient experienced a severe allergic reaction with excessive sneezing, coughing, eye swelling, hives and hands and feet itching. He was treated with diphenhydramine. The allergic reaction was completely resolved on 28-Aug-2009 with sneezing, coughing, hives and hand and feet itching resolved on 27-Aug-2009. The eye swelling resolved the following day.
Information has been received from a RN concerning a pt who on 27Nov95 was vaccinated with a dose of varicella virus vaccine live (lot 610255/0748B). Subsequently, on 02May01, the pt developed chickenpox. The pt was seen in the office. The reporter also indicated that 30 other pts were vaccinated with varicella virus vaccine live and developed chickenpox (WAES0409USA00600, WAES0409USA01045, WAES0409USA01046, WAES0409USA01047, WAES0409USA01048, WAES0409USA01049, WAES0409USA01050, WAES0409USA01051, WAES0409USA01052, WAES0409USA01053, WAES0409USA01054, WAES0409USA01055, WAES0409USA01056, WAES0409USA01057, WAES0409USA01058, WAES0409USA01059, WAES0409USA01060, WAES0409USA01061, WAES0409USA01062, WAES0409USA01063, WAES0409USA01065, WAES0409USA01066, WAES0409USA01067, WAES0409USA01068, WAES0409USA01069, WAES0409USA01070, WAES0409USA01071, WAES0409USA01072, WAES0409USA01073, WAES0409USA01074). No further information is expected.
Mom states temp was 106 12 hrs p/DTP vax & for 10 to 12hrs; Mom did not seek tx @ that time, but notified clinic on 17OCT91 @ routine visit;
Pt received first 2 COVID vaccines from moderna. Pt received Pfizer booster. Pt @10min mark reported light-headedness, gave water. Reported nausea at 30min mark symptoms improved.
I had a breakthrough COVID-19 infection 3 months after my third dose. My symptoms included rhinorrhea and mild headache.  My symptoms lasted for about 4 days.  My home COVID-19 test was positive on day 5 and positive on day 10.
Developed an intention tremor about 7 hours after 2 nd dose.  Noticed by my dentist same day as my vaccine.  Noticed by myself and all of my coworkers.  I am a nurse practitioner and my patient's notice is and comment during examination.  Unable to do sports I have always done that require hand eye coordination.  about 2 weeks after vaccination become numb over total body, Have had basic labs and auto immune panel.  All have been completely normal.  I have been referred to neurologist.  Waiting to get an appointment.
I got the Pfizer shot then not 15 mins. lather I had a server allergic and ended up in the hospital. i do not know why I had the allergic reaction.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 23 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 06Apr2021 (Batch/Lot number: unknown) at the age of 23 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "diagnosed with APL Leukemia curtly 4 years cancer free", start date: 13Dec2016 (unspecified if ongoing); "Known allergies:i have a long list to medications" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: HYPERSENSITIVITY (hospitalization) with onset 06Apr2021, outcome "recovered" (2021), described as "I got the Pfizer shot then not 15 mins. lather I had a server allergic and ended up in the hospital. i do not know why I had the allergic reaction". The patient was hospitalized for hypersensitivity (start date: 06Apr2021). The event "i got the pfizer shot then not 15 mins. lather i had a server allergic and ended up in the hospital. i do not know why i had the allergic reaction." was evaluated at the physician office visit. Therapeutic measures were taken as a result of hypersensitivity. Prior to the COVID vaccine the patient did not receive any other vaccines within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Epinephrine with 2 different er visits was treatment received for the adverse event.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient sustained DVT on 5/26/2021 after receiving Moderna COVID-19 vaccine on 5/17/2021.   patient has history of prostate cancer that was diagnosed 6 weeks ago with prostate cancer.  No previous clot history.
Has slight fever muscle aches sore arm chills and headache gave him Bayer aspirin for aches and fever feels a little better
Arthralgias soon after hepatitis B vaccines. Subsequently diagnosed with rheumatoid arthritis.
Had shot after 2nd time, did not work/ suspected vaccination failure; Had shingles 3 times /around abdomen and ribcage, head, neck, ears; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Had shot after 2nd time, did not work/ suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Had shingles 3 times /around abdomen and ribcage, head, neck, ears). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 22-MAR-2023 This case was reported by patient via interactive digital media. The patient had shingle 3 times, twice around abdomen and ribcage, 3rd time on head, neck and ears. The patient had shot after first or 2nd, did not work. No more shots for himself/herself. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. Follow up was not possible, as no contact details were available.
No additional AE; patient erroneously received a dose of PNEUMOV AX 23 instead of the intended dose of PREVNAR 13 .; This spontaneous report has been received from a healthcare professional, and refers to a patient of unknown age and gender. Information regarding the patient's concurrent conditions, medical history and concomitant medications was not provided.  On 02-NOV-2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (dose, route, lot number and expiration date not reported), then, on 14-DEC-2021, the patient erroneously received another dose pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) lot # U018309 and expiration date 08-JAN-2023, 0.5 milliliter (route not reported) for prophylaxis; instead of the intended dose of pneumococcal vaccine conj 13v (crm197)(PREVENAR 13) (Wrong vaccine administered). No additional adverse event (AE) or product quality complaint (PQC) reported.
shortness of breath/ can't take full breath; Sore arm; tightness in chest; fatigue; This is a spontaneous report from a contactable consumer (Patient).  A 40 years-old non-pregnant female patient received bnt162b2 (BNT162B2, Lot Number: FH8027), via Intramuscular on arm left on 14Nov2021 10: 00 AM (at the age of 40 years-old) as dose 1, single for COVID-19 immunization at a Pharmacy or drug store. The patient's medical history was not reported. The patient did not take any other medications in two weeks. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. On 15Nov2021, the patient experienced shortness of breath/ can't take full breath, sore arm, tightness in chest and fatigue. On 15Nov2021 08: 00 AM, the patient underwent lab tests and procedures which included Nasal Swab: Pending. The patient did not receive any treatment for adverse event. The outcome of events was recovering.  Follow-Up (18Nov2021): Follow-up attempts are completed. No further information is expected.
She immediately felt pain from the left side of her beck down to her fingertips and has tingling at her fingertips; Has tingling at her fingertips; This is a spontaneous report received from a contactable Consumer or other non HCP from medical information team. The reporter is the patient.  A 49 year-old female patient received bnt162b2 (BNT162B2), administration date 19May2021 (Batch/Lot number: unknown) at the age of 49 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st Dose), for Covid-19 Immunization. The following information was reported: BACK PAIN (non-serious) with onset 19May2021, outcome "unknown", described as "She immediately felt pain from the left side of her beck down to her fingertips and has tingling at her fingertips"; PARAESTHESIA (non-serious) with onset 19May2021, outcome "unknown", described as "Has tingling at her fingertips". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt started feeling dizzy, eyes rolled, lost consciousness for a few seconds, lethargic, nauseous, pale, low BP
Patient reported not feeling well  with nausea at home less than 1.5 hours after receiving 2 vaccines in our office, then had witnessed  tonic clonic seizure ( loss of consciousness with eyes rolling back and convulsive movements of upper extremities and torso for 2 minutes, then sleepy and lethargic ) and brought to by ambulance to ER in post ictal state. No previous history of seizures. Patient discharged home form the ER same day w. Instructions to see Neurologist and Pediatric PCP for follow up. Seen by Neurologist 6/22/20, has not had any further seizure activity since and patient is feellng well. MRI and EEG to be performed, no medications started except  rectal Diastat hould patient have another seizure.
Slight pressure on my chest for about a minute, which slightly impaired my breathing.  Occurred within a minute of receiving the shot. The pressure went away after about a minute and I haven?t experienced any other side effects since then. Not even a sore arm.
This case was reported by a physician and described the occurrence of laboratory test interference in a female subject in her late 20's who was vaccinated with HAVRIX, (GlaxoSmithKline).  On an unspecified date the subject received unspecified dose of HAVRIX (1 ml, unknown).  It was unknown if other vaccinations were given on the same day as HAVRIX.  Three weeks after vaccination with HAVRIX, the subject tested positive for HIV.  The physician was concerned about any possible laboratory test interference on the HIV test due to the HAVRIX vaccination.  At the time of reporting the possible laboratory interference was unresolved.  The outcome of testing positive for HIV was unspecified.  The physician considered the possible laboratory interference was possibly related to vaccination with HAVRIX.  The causality for testing positive for HIV was unspecified.
Rolling eyes, regurgitation of feeding, possible apnea episode. Admitted to hospital. Observation for 24 hour monitoring in hospital.
Pt. had a shingle vaccine 6/16/2016. Pt. was seen at clinic today for rash noted left side dermatome- bra line. Pt. states began hurting 10 days ago and broke out in the past few days. Pt. diagnosed today with shingles and treated.
Large local reaction; Weaknessin lower extremities; This case was reported by a nurse via call center representative and described the occurrence of local reaction in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included walking aid user (uses a walker and a cane).   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced local reaction and lower extremities weakness of. On an unknown date, the outcome of the local reaction and lower extremities weakness of were unknown.   It was unknown if the reporter considered the local reaction and lower extremities weakness of to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported.  Post vaccination with Shingrix the patient experienced a large local reaction and felt weakness in their lower extremities. The reporter consented to follow up. No further details regarding events or vaccine was given.  It was unknown who administered the vaccine.
This spontaneous report was received from a consumer refers to herself as a female patient of unknown age. On 26-SEP-2013, the patient was vaccinated with first dose of GARDASIL (dose, route and frequency were not reported). It was reported that the patient still not received second dose of GARDASIL. No adverse effects were reported. No further information was provided. Additional information has been requested.
28Jan97 pt recv 1 dose vax. 04Mar98 pt devel "greater than 50 lesions all over the body". Lesions described as "all stages vesicles". Pt tx & "vesicles clearing up". Pt sibling similar exp WAES98030691
Both times.was in bed several days felt so like really bad flu; Both times.was in bed several days felt so like really bad flu; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of influenza-like symptoms in a 57-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced influenza-like symptoms (Verbatim: Both times.was in bed several days felt so like really bad flu) and bedridden (Verbatim: Both times.was in bed several days felt so like really bad flu). The outcome of the influenza-like symptoms and bedridden were resolved.   It was unknown if the reporter considered the influenza-like symptoms and bedridden to be related to Shingles vaccine.     It was unknown if the company considered the influenza-like symptoms and bedridden to be related to Shingles vaccine.   Linked case(s) involving the same patient:  US2023AMR067492   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. Last year the patient got Shingles shot vaccine. Both times the patient was in bed several days felt so like really bad flu. Follow-up would not possible as no contact details were available. For tolerance to the 2nd dose refer case US2023AMR067492.; Sender's Comments:  US-GSK-US2023AMR067492:same patient
Patient reports initially swelling in the arm, but has had dizziness and especially with position change since that vaccine. It is now 6 months and symptoms are resolving.
swollen at the injection site; arm was very sore; This case was reported by a consumer via interactive digital media and described the occurrence of injection site swelling in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced injection site swelling and injection site pain. On an unknown date, the outcome of the injection site swelling and injection site pain were recovered/resolved.   It was unknown if the reporter considered the injection site swelling and injection site pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 25-JUL-2022 Reporter's Comments: This case was reported by patient via interactive digital media. The patient got the Shingles vaccine shot and her arm was very sore and swollen at the injection site for about a week. However, it was nothing compared to the shingles that her husband was suffering with for 5 weeks so far.  Additional Supportive Information: The follow-up would not possible as no contact details were available.
Pt received vaccine on 3/20/06. Pt expired at home on 3/22/06. 7/10/06 Received autopsy report which revealed COD as persistence of fetal circulation/ss
Patient came for booster (3rd shot) and received Moderna.  Previous vaccine series was Pfizer.
Patient was feeling fatigued, experiencing malaise, weak for most of the day shortly after receiving the flu vaccine. Symptoms did not appear until 30mins-1 hour after admin.
I received the vaccine on 1/19/2021 at my place of employment. Upon getting the vaccine approx 30 minutes after receiving i became very itcy, and my lips were burning/tingling. The itching continued to get worse, forming red rash on my chest. I called my MD at this point. I was told to take benadryl and to go to er if it became worse. I took benadryl. the itching continued for 2 days. i also experienced pain at injection site, headache, nausea, diarrhea, extreme fatigue, muscle soreness. on 2nd day after vaccine i woke up and my muscles continued to be very sore. like i had just completed a marathon. I also have this sensation that started with the increased muscle pain. The only way i can explain it is that it feels like how a TENS unit feels, but its coming from the inside. especially in my back and thighs. this continues. i feel like i could just start shaking at any time. i cannot sleep but i am so tired. i was seen at dr today and i was told to report this to you guys. this sensation has not went away and has actually cause my muscles to spasming. MD said the vaccine effected my muscles and possibly neurologically as well.
About 10 days after vaccination my blood pressure was 172/102 but dropped after sitting for while at urgent care to 159/89. Both shoulders were hurting that I was unable to lift my arms. Unbearable headache, dizziness and spinning. Pain in the shoulders last for four month ( September 2021) and than the pain travel to my knees, mainly left one. Unable to walk without pain medications (January 29, 2022)  I received cortisone shot to left knee.  In February 2022 the pain shifted to my left side of neck and month later back to  left shoulder. As of now I am unable to function without pain medications.
CHILD WOKR UP AT 7:00 AM ON 6/23/23022 AND TOLD HIS MOTHER HER HAD LAVA ON HIS ARM . LEFT ARM FROM SHOULDER TO ELBOW, EDEMATOUS,CIRCUMFERENTIAL ERYTHEMA AND HOT TO TOUCH. NO FEVER,CHILD DENIES PAIN, WENT TO DAY CARE